Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years
Clinical trial NCT03233217 · COMPLETED
Trial details
- NCT number
- NCT03233217
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-15
- Primary completion
- 2017-11-28
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.